FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 104 filers reported holding FIBROGEN INC in Q2 2024. The put-call ratio across all filers is 0.43 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $8,923 | -88.5% | 10,000 | -69.7% | 0.00% | – |
Q1 2024 | $77,597 | +155.5% | 33,020 | -3.6% | 0.00% | – |
Q4 2023 | $30,369 | +53.4% | 34,265 | +49.4% | 0.00% | – |
Q3 2023 | $19,796 | -94.0% | 22,941 | -81.1% | 0.00% | – |
Q2 2023 | $328,014 | -80.6% | 121,487 | +34.3% | 0.00% | – |
Q1 2023 | $1,687,910 | +333.1% | 90,456 | +271.8% | 0.00% | – |
Q4 2022 | $389,750 | +621.8% | 24,329 | +494.7% | 0.00% | – |
Q3 2022 | $54,000 | +5.9% | 4,091 | -16.8% | 0.00% | – |
Q2 2022 | $51,000 | -91.1% | 4,916 | -89.7% | 0.00% | – |
Q1 2022 | $572,000 | -45.4% | 47,601 | -36.0% | 0.00% | – |
Q4 2021 | $1,048,000 | +9.5% | 74,332 | -20.6% | 0.00% | – |
Q3 2021 | $957,000 | -67.4% | 93,594 | -15.2% | 0.00% | -100.0% |
Q2 2021 | $2,940,000 | -44.8% | 110,410 | -28.0% | 0.00% | 0.0% |
Q1 2021 | $5,322,000 | -8.2% | 153,312 | -1.9% | 0.00% | 0.0% |
Q4 2020 | $5,796,000 | -17.8% | 156,271 | -8.9% | 0.00% | -50.0% |
Q3 2020 | $7,050,000 | +11.3% | 171,459 | +9.7% | 0.00% | 0.0% |
Q2 2020 | $6,337,000 | +35.3% | 156,334 | +16.0% | 0.00% | 0.0% |
Q1 2020 | $4,685,000 | -12.5% | 134,805 | +8.0% | 0.00% | +100.0% |
Q4 2019 | $5,354,000 | +3.6% | 124,822 | -10.6% | 0.00% | 0.0% |
Q3 2019 | $5,167,000 | -18.2% | 139,689 | -0.1% | 0.00% | -50.0% |
Q2 2019 | $6,320,000 | -72.2% | 139,898 | -66.6% | 0.00% | -71.4% |
Q1 2019 | $22,768,000 | +552.8% | 418,911 | +455.9% | 0.01% | +600.0% |
Q4 2018 | $3,488,000 | -26.6% | 75,360 | -3.7% | 0.00% | 0.0% |
Q3 2018 | $4,755,000 | -6.0% | 78,275 | -3.1% | 0.00% | 0.0% |
Q2 2018 | $5,058,000 | +67.2% | 80,800 | +23.4% | 0.00% | 0.0% |
Q1 2018 | $3,026,000 | -3.0% | 65,486 | -31.4% | 0.00% | 0.0% |
Q4 2017 | $3,120,000 | -44.6% | 95,501 | -8.8% | 0.00% | -50.0% |
Q3 2017 | $5,634,000 | +155.7% | 104,733 | +53.5% | 0.00% | +100.0% |
Q2 2017 | $2,203,000 | +44.1% | 68,229 | +10.0% | 0.00% | – |
Q1 2017 | $1,529,000 | +48.4% | 62,037 | +29.0% | 0.00% | – |
Q4 2016 | $1,030,000 | +36.8% | 48,109 | +32.2% | 0.00% | – |
Q3 2016 | $753,000 | +113.3% | 36,386 | +69.2% | 0.00% | – |
Q2 2016 | $353,000 | -42.3% | 21,511 | -25.3% | 0.00% | – |
Q1 2016 | $612,000 | +13.3% | 28,783 | +62.5% | 0.00% | – |
Q4 2015 | $540,000 | +6.7% | 17,712 | -23.3% | 0.00% | – |
Q3 2015 | $506,000 | +30.7% | 23,083 | +40.1% | 0.00% | – |
Q2 2015 | $387,000 | +339.8% | 16,480 | +499.3% | 0.00% | – |
Q1 2015 | $88,000 | – | 2,750 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 1,735,677 | $93,379,000 | 12.44% |
Omega Fund Management, LLC | 314,348 | $16,912,000 | 9.57% |
Opaleye Management Inc. | 360,000 | $19,368,000 | 6.85% |
NEXTHERA CAPITAL LP | 217,329 | $11,692,000 | 3.01% |
Monashee Investment Management LLC | 122,300 | $6,580,000 | 2.49% |
Hillhouse Capital Management | 2,486,196 | $133,757,000 | 2.21% |
DOHENY ASSET MANAGEMENT /CA | 50,925 | $2,740,000 | 1.26% |
Sicart Associates LLC | 31,072 | $1,672,000 | 1.20% |
Iguana Healthcare Management, LLC | 80,000 | $4,304,000 | 1.19% |
Rhenman & Partners Asset Management AB | 145,500 | $7,828,000 | 1.00% |